Zhai Pei-Bin, Ma Lan, Liu Xing
Pharmacology Research Center, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Sheng Li Xue Bao. 2016 Dec 25;68(6):790-798.
G protein-coupled receptors (GPCRs) mediate signal transduction via G protein or β-arrestin. Several biased ligands and receptors that preferentially signal through either G protein- or β-arrestin-mediated pathways have been identified. These discoveries have redefined the classical GPCR signaling paradigm. Distinct ligand-receptor binding sites might be one of the main reasons for biased signal transduction. It is posited that multiple active conformations of receptors lead to distinct kinase phosphorylation patterns on C terminus of receptors. Phosphorylation patterns decide which signal pathway will be transduced. The biased signal pathway transduction has been found in more than 40 GPCRs till now. A few of them have been found involved in fine-regulation of physiological processes. However, most others still need further investigation. The biased ligands may be developed as tools for understanding the basic physiology of GPCR, and, potentially and most importantly, as fine-tuned therapeutics that maximize beneficial effects and minimize adverse or unwanted effects. These studies will provide new insights into new drug discovery.
G蛋白偶联受体(GPCRs)通过G蛋白或β-抑制蛋白介导信号转导。已经鉴定出几种偏向性配体和受体,它们优先通过G蛋白或β-抑制蛋白介导的途径发出信号。这些发现重新定义了经典的GPCR信号传导模式。不同的配体-受体结合位点可能是偏向性信号转导的主要原因之一。据推测,受体的多种活性构象导致受体C末端不同的激酶磷酸化模式。磷酸化模式决定了将转导哪种信号通路。到目前为止,在40多种GPCR中发现了偏向性信号通路转导。其中一些已被发现参与生理过程的精细调节。然而,大多数其他情况仍需要进一步研究。偏向性配体可能被开发为理解GPCR基本生理学的工具,并且潜在地且最重要的是,作为微调疗法,以最大化有益效果并最小化不良或有害影响。这些研究将为新药发现提供新的见解。